-
1 Comment
Centene Corporation is currently in a long term uptrend where the price is trading 11.9% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.
Centene Corporation's total revenue rose by 50.0% to $28B since the same quarter in the previous year.
Its net income has dropped by 105.7% to $-12M since the same quarter in the previous year.
Finally, its free cash flow grew by 426.1% to $3B since the same quarter in the previous year.
Based on the above factors, Centene Corporation gets an overall score of 4/5.
ISIN | US15135B1017 |
---|---|
Sector | Healthcare |
Industry | Healthcare Plans |
Exchange | NYSE |
CurrencyCode | USD |
Dividend Yield | None |
---|---|
PE Ratio | 9.54 |
Target Price | 79.5 |
Beta | 0.53 |
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, federal, and corporate management services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CNC using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025